News

It was with great sadness that the EMCDDA learned this week of the passing of its long-term friend and colleague Tomáš Zábranský MD, PhD. Dr Zábranský was a highly-esteemed Czech epidemiologist, who...

Contingency Management – evidence continues to build-up, time to start talking about implementation? According to the just published EMCDDA European Drug Report cocaine is the second most commonly used illicit drug in...

This content was published in the EU4MD update released on 30.06.2021. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner. Focus on: European Drug Report...

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)( 1). Released on the eve of...

The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025. The new plan presents the concrete actions needed to achieve the priorities of the...

Resilience, agility and innovation are among the recurring themes in the latest EMCDDA General Report of Activities, released today. The annual publication — presenting key achievements and governance — relates how the...

Today, the EU drugs agency (EMCDDA) publishes its European Drug Report 2021: Trends and Developments, the latest annual review of the drug situation in Europe ( 1). Based on data from 29...

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) ( 1). Often marketed as ‘designer...

Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way in which we live. Countries in Europe, and around the world, have had to introduce unprecedented measures to...

The new EU Drugs Strategy 2021–25 makes explicit that the European response to drugs should be evidence-based and delivered through a balanced and integrated approach, which ultimately must be judged on its...

How has the COVID-19 pandemic affected drug use and supply? What drugs are causing the most concern today? What are the latest trends in drug production and trafficking? Find out more when...

The 2020 findings from the largest European project in the science of wastewater analysis are revealed today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wide SCORE...

In the last few weeks, three US states have legalised cannabis for recreational purposes, all via the legislature and not via public ballots. New York, Virginia and New Mexico will begin by...

The EMCDDA has launched today its first bilateral technical cooperation project with Georgia aimed at enhancing national responses to drug-related health and security threats. The EMCDDA4Georgia project (EMCDDA4GE) will focus primarily on...

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies...

Austrian Federal Minister for the European Union and Constitution Karoline Edtstadler, visits the EMCDDA today where she will meet EMCDDA Director Alexis Goosdeel. The Minister will receive a briefing on the agency’s...

This content was published in the EU4MD update released on 16.04.2021. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner. Focus on: Methamphetamine trade in...

School-based programmes to improve mental health and well-being and reduce risks Adolescents spend a significant part of their lifetime in school and, therefore, this environment plays an important role in their social...

European Commissioner for Home Affairs Ylva Johansson paid her first visit to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) today during a day of events relating to the fight...

Do you use drugs? How many? How often? These are among the questions posed in the latest European Web Survey on Drugs, launched today by the EU drugs agency (EMCDDA). Targeted at...